HMG-CoA reductase inhibitors, commonly referred to as statins, are the cornerstone of pharmacologic reduction of elevated low-density lipoprotein cholesterol. LDL-C is the main contributor to ...

HMG Strategy, the world’s leading platform for empowering technology executives to reimagine the enterprise and reshape the ...

HMG’s hospitals and medical facilities treated more than 5.3 million patients in 2022. It is establishing six projects at a total cost of $2.1 billion to add 1,556 beds to the current capacity by 2025 ...